Regression of Barrett’s Esophagus With Proton Pump Inhibitor Therapy

Progress of Digestive Endoscopy

doi 10.11641/pde.73.2_36

Full Text

Abstract

Available in

Date

Authors

Publisher

Japan Gastrointestinal Endoscopy Society

Related search

Proton Pump Inhibitor-Amoxicillin-Clarithromycin Versus Proton Pump Inhibitor-Amoxicillin-Metronidazole as First-Line Helicobacter Pylori Eradication Therapy

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2012English

Adherence to Therapy for Barrett’s Esophagus-Associated Neoplasia

United European Gastroenterology Journal
OncologyGastroenterology
2015English

Hypomagnesemia Associated With a Proton Pump Inhibitor

Internal Medicine
Internal MedicineMedicine
2012English

Predictors of Response to Proton Pump Inhibitor Therapy Among Children With Significant Esophageal Eosinophilia

Pediatrics
Child HealthPediatricsPerinatology
2009English

Increased Clostridium Difficile Recurrences Following Combined Proton Pump Inhibitor–Metronidazole Therapy

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2014English

Endoscopic Eradication Therapy for Patients With Barrett’s Esophagus–associated Dysplasia and Intramucosal Cancer

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2018English

Fundic Gland Polyposis Associated With Proton-Pump Inhibitor Use

European Journal of Case Reports in Internal Medicine
Internal Medicine
2017English

Choice of Optimal Proton Pump Inhibitor for Patients With Ischemic Heart Disease Who Require Dual Antiplatelet Therapy

HYPERTENSION
2018English

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth

Gastroenterology
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy